Literature DB >> 8611183

Altered methional homoeostasis is associated with decreased apoptosis in BAF3 bcl2 murine lymphoid cells.

A M Roch1, G Quash, Y Michal, J Chantepie, B Chantegrel, C Deshayes, A Doutheau, J Marvel.   

Abstract

Methional is a potent inducer of apoptosis in an interleukin 3-dependent murine lymphoid cell line BAF3 b0 when it is added to the culture medium. In these cells transfected with the bcl2 gene, BAF3 bcl2, the apoptotic-inducing activity of methional is dramatically reduced. The addition of disulfiram (an inhibitor of aldehyde dehydrogenase) in order to reduce methional oxidation brought about an increase in apoptosis in BAF3 b0 but not in BAF3 bcl2 cells. In contrast, the addition of quercetin (an inhibitor of aldehyde reductase) in an attempt to diminish methional reduction increased apoptosis in both BAF3 b0 and BAF3 bcl2 cells. The extent of DNA fragmentation in BAF3 bcl2 cells approached that in BAF3 b0 cells in the presence of quercetin and exogenous methional, suggesting a defect in methional biosynthesis in BAF3 bcl2 cells. Direct evidence for this was obtained by measuring labelled methional in cells incubated with the sodium, salt of [U-14C]4-methylthio-2-oxobutanoic acid (MTOB), the precursor of methional. The 80% decrease in labelled methional in BAF3 bcl2 compared with BAF3 b0 cells was accompanied by a concomitant rise in the transamination of [14C]MTOB to [14C]methionine in BAF3 bcl2 cells. Inhibition of the transaminase, however, by a synthetic transition-state-type compound, pyridoxal-L-methionine ethyl ester, induced apoptosis in BAF3 b0 but not in BAF3 bcl2 cells, confirming that the defect in BAF3 bcl2 cells was not in the transaminase itself but rather in the oxidative decarboxylation step MTOB --> methional. In addition, no evidence was obtained for the synthesis of [14C]malondialdehyde from [14C]methional in BAF3 bcl2 cells. As these cells show no deficiency in their content of reactive oxygen species compared with that of BAF3 b0 cells, they may possess some other defect in the beta-hydroxylase enzyme system itself.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611183      PMCID: PMC1217006          DOI: 10.1042/bj3130973

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis.

Authors:  D M Hockenbery; Z N Oltvai; X M Yin; C L Milliman; S J Korsmeyer
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

3.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

Authors:  Z N Oltvai; C L Milliman; S J Korsmeyer
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

4.  Contribution of 4-methylthio-2-oxobutanoate and its transaminase to the growth of methionine-dependent cells in culture. Effect of transaminase inhibitors.

Authors:  G Ogier; J Chantepie; C Deshayes; B Chantegrel; C Charlot; A Doutheau; G Quash
Journal:  Biochem Pharmacol       Date:  1993-04-22       Impact factor: 5.858

5.  Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes.

Authors:  S Krajewski; S Tanaka; S Takayama; M J Schibler; W Fenton; J C Reed
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

6.  Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway.

Authors:  W D Jarvis; R N Kolesnick; F A Fornari; R S Traylor; D A Gewirtz; S Grant
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

7.  Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species.

Authors:  D J Kane; T A Sarafian; R Anton; H Hahn; E B Gralla; J S Valentine; T Ord; D E Bredesen
Journal:  Science       Date:  1993-11-19       Impact factor: 47.728

8.  Induction of apoptosis by quercetin: involvement of heat shock protein.

Authors:  Y Q Wei; X Zhao; Y Kariya; H Fukata; K Teshigawara; A Uchida
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

9.  Programmed cell death and Bcl-2 protection in the absence of a nucleus.

Authors:  M D Jacobson; J F Burne; M C Raff
Journal:  EMBO J       Date:  1994-04-15       Impact factor: 11.598

10.  Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.

Authors:  F Oberhammer; J W Wilson; C Dive; I D Morris; J A Hickman; A E Wakeling; P R Walker; M Sikorska
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  2 in total

1.  ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.

Authors:  M Pérez-Alea; K McGrail; S Sánchez-Redondo; B Ferrer; G Fournet; J Cortés; E Muñoz; J Hernandez-Losa; S Tenbaum; G Martin; R Costello; I Ceylan; V Garcia-Patos; J A Recio
Journal:  Oncogene       Date:  2017-06-05       Impact factor: 9.867

2.  Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.

Authors:  G Venton; M Pérez-Alea; C Baier; G Fournet; G Quash; Y Labiad; G Martin; F Sanderson; P Poullin; P Suchon; L Farnault; C Nguyen; C Brunet; I Ceylan; R T Costello
Journal:  Blood Cancer J       Date:  2016-09-09       Impact factor: 11.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.